BIB

Equity ETFs

Checking Up on Health Care ETFs Ahead of 2018

By Special To ETF TrendsDecember 14, 2017

Equity ETFs

Evaluating the Biotech ETF Rally

By Tom LydonSeptember 28, 2017

Equity ETFs

Biotech, Pharma ETFs Leave Pricing Drama Behind

By Max ChenSeptember 15, 2017

Equity ETFs

Biotech ETF Investing is Hot, Can Get Hotter

By Tom LydonSeptember 8, 2017

Equity ETFs

September Could be Kind to Biotechnology ETFs

By Brenton GarenAugust 29, 2017

Equity ETFs

Biotech ETFs Prescribe Investing Momentum

By Tom LydonJuly 24, 2017

Equity ETFs

Encouraging Signs for a Big Biotech ETF

By Tom LydonMay 8, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Upside Coming for Biotech ETFs Against Challenging Political Backdrop

By Brenton GarenMarch 30, 2017

Equity ETFs

Third-Largest Biotech ETF Up 20% Year-to-Date

By Brenton GarenMarch 14, 2017

Equity ETFs

Another Endorsement for a Big Biotech ETF

By Brenton GarenMarch 13, 2017

Equity ETFs

Biotech ETFs Look Promising as White House May Help FDA Expedite Drug Approvals

By Tom LydonMarch 10, 2017

Equity ETFs

Biotech ETFs Unwind Political Risk After Trump Victory

By Max ChenNovember 11, 2016

Alternative ETFs

Capitalizing on the Biotech Rebound with Leveraged ETFs

By Max ChenApril 18, 2016

Contributed

ETF Chart of the Day: Hot Biotechnology Sector

By Paul Weisbruch, Street One FinancialJuly 30, 2015

Featured

Impressive Bull Run in Biotech ETFs Causes Some to Take Pause

By Tom LydonJuly 16, 2015

Featured

Traders Bet on new Leveraged Biotech ETFs

By Todd ShriberJuly 15, 2015

Featured

ProShares Announces Splits for 21 ETFs

By Tom LydonMay 4, 2015